Cardiovascular Disease Clinical Research  

Reducing the burden of cardiovascular disease in patients


As a leading life-shortening disease, cardiovascular diseases are critical to prevent and treat immediately in patients around the world. The clinical trial process is complicated and full of unknowns, and even the best cardiovascular therapeutic might not make it to the patients that need it, not because it does not work but because the design, data collection, and analysis were not done right.

At Veristat, we have assembled an extraordinary team of scientific-minded experts who have mastered the complexities of running cardiovascular disease trials. We have supported more than 200 clinical trials for cardiovascular treatments, diagnostics, and medical devices.

Improving Cardiovascular Disease Outcomes Through Expertise

The acute nature of most cardiology/vascular diseases makes them highly complex to treat.  Our diverse trial experience, coupled with our knowledgeable and experienced teams, allows us to confidently handle the most complex trials and patient populations with the attention and focus needed to navigate the cardiology/vascular disease landscape.

At Veristat, our experienced teams are poised to plan and implement these efforts quickly providing:     
Veristat_icon_cardiovascular

> 200

clinical trials supported for Cardiovascular Disorders
Veristat_icon_rare-disease-216

> 40%

of these clinical trials are RARE DISORDERS
Veristat_icon_regulatory-approval-216-1

> 65%

Marketing Applications prepared are approved, to date

Explore Our Recent Cardiology Experience

Driving Successful Outcomes for Cardiovascular Trials
  
Abdominal Aortic Aneurysm (AAA) 
   
Ehlers-Danlos Syndrome (EDS) 
   
Ischemic Heart Disease 
  
Acute Coronary Syndrome
  
Electrocardiogram (ECG)
  
Myocardial Infarction
  
Acute Hereditary Angioedema Attacks
  
Endocarditis
   
Pericarditis
  
Blood/Brain Barrier Crossing of Drug
  
Familial Chylomicronemia Syndrome (FCS)
  
Raynaud's Disease
  
Cardiac Fibrosis
  
Heart Failure
  
Stroke - Aneurysmal Subarachnoid Hemorrhage (aSAH)
  
Cardiac Imaging
  
Hereditary Transthyretin Amyloidosis (hATTR)
  
Treatment after Creation of Arteriovenous Access for Hemodialysis Use
  
Coronary Arterial Restenosis
  
Homozygous Familial Hypercholesterolemia (HoFH)
  
Vascular Access Graft
  
Coronary Artery Bypass Grafting (CABG)
  
Hyperlipoproteinemia(a) and Established Cardiovascular Disease (CVD)
  
Vascular Ehlers-Danlos Syndrome (EDS)
  
Coronary Artery Disease
  
Hypertension
   
Vascular Injury
  
Critical Limb Ischemia
  
Hypertriglyceridemia
  
Venous Leg Ulcers (VLU)

 

Learn More with These Resources
Webinar Presentation
Webinar: Virtual Trial Planning Lessons Learned

Get the webinar presentation to see lessons learned and recommendations for designing protocols that enable flexibility in your virtual trials' ...

open
Case Study
Writing Multiple Marketing Applications At The Same Time

A mid-size pharmaceutical company and its development partner, a small biotechnology company engaged Veristat to complete the medical writing for their product’s ...

download
Fact Sheet
Cardiovascular Experience Fact Sheet

With Cardiovascular Diseases being the leading cause of death worldwide, Veristat is committed to supporting cardiovascular clinical trials to make a difference in ...

download
Request A Proposal
  • Privacy Policy
  • ©2006 - 2021 Veristat, LLC. All rights reserved. Veristat is a trademark of Veristat, LLC. All other trademarks are the property of their respective owners.